Petra Ross‐Macdonald

16.0k total citations
39 papers, 2.5k citations indexed

About

Petra Ross‐Macdonald is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Petra Ross‐Macdonald has authored 39 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 15 papers in Oncology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Petra Ross‐Macdonald's work include Cancer Immunotherapy and Biomarkers (13 papers), Renal cell carcinoma treatment (10 papers) and Fungal and yeast genetics research (10 papers). Petra Ross‐Macdonald is often cited by papers focused on Cancer Immunotherapy and Biomarkers (13 papers), Renal cell carcinoma treatment (10 papers) and Fungal and yeast genetics research (10 papers). Petra Ross‐Macdonald collaborates with scholars based in United States, Germany and France. Petra Ross‐Macdonald's co-authors include G. Shirleen Roeder, M Snyder, Eun Young Choi, Karin E. Finberg, Amy E. Sheehan, Brian G. Grimwade, J. Novak, Nathan O. Siemers, Scott D. Chasalow and Thomas M. Menees and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Petra Ross‐Macdonald

37 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Petra Ross‐Macdonald United States 22 1.9k 352 318 313 268 39 2.5k
Nathan J. Bowen United States 26 1.9k 1.0× 408 1.2× 606 1.9× 232 0.7× 202 0.8× 49 2.8k
Anthony J. Davis United States 27 2.0k 1.0× 780 2.2× 291 0.9× 210 0.7× 253 0.9× 62 2.8k
Philip M. Sass United States 19 2.3k 1.2× 296 0.8× 363 1.1× 401 1.3× 168 0.6× 32 3.0k
Tokameh Mahmoudi Netherlands 27 2.4k 1.3× 339 1.0× 133 0.4× 191 0.6× 93 0.3× 56 3.2k
Pascale Bertrand France 25 2.6k 1.4× 721 2.0× 263 0.8× 237 0.8× 124 0.5× 50 3.0k
Lawrence Weissbach United States 21 1.7k 0.9× 746 2.1× 220 0.7× 445 1.4× 211 0.8× 34 2.6k
James W. Peacock Canada 24 931 0.5× 525 1.5× 170 0.5× 141 0.5× 201 0.8× 41 1.6k
Philippe Coulombe France 23 2.2k 1.2× 459 1.3× 158 0.5× 367 1.2× 52 0.2× 30 2.5k
Anita Saraf United States 26 2.7k 1.4× 443 1.3× 214 0.7× 583 1.9× 83 0.3× 41 3.4k
Helen Yu United States 19 1.3k 0.7× 297 0.8× 135 0.4× 297 0.9× 196 0.7× 26 2.0k

Countries citing papers authored by Petra Ross‐Macdonald

Since Specialization
Citations

This map shows the geographic impact of Petra Ross‐Macdonald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Ross‐Macdonald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Ross‐Macdonald more than expected).

Fields of papers citing papers by Petra Ross‐Macdonald

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra Ross‐Macdonald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Ross‐Macdonald. The network helps show where Petra Ross‐Macdonald may publish in the future.

Co-authorship network of co-authors of Petra Ross‐Macdonald

This figure shows the co-authorship network connecting the top 25 collaborators of Petra Ross‐Macdonald. A scholar is included among the top collaborators of Petra Ross‐Macdonald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra Ross‐Macdonald. Petra Ross‐Macdonald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mahoney, Kathleen M., Petra Ross‐Macdonald, Long Yuan, et al.. (2022). Soluble PD-L1 as an early marker of progressive disease on nivolumab. Journal for ImmunoTherapy of Cancer. 10(2). e003527–e003527. 55 indexed citations
2.
Krijgsman, Oscar, Kristel Kemper, Julia Boshuizen, et al.. (2021). Predictive Immune-Checkpoint Blockade Classifiers Identify Tumors Responding to Inhibition of PD-1 and/or CTLA-4. Clinical Cancer Research. 27(19). 5389–5400. 3 indexed citations
3.
Ross‐Macdonald, Petra, Alice M. Walsh, Scott D. Chasalow, et al.. (2021). Molecular correlates of response to nivolumab at baseline and on treatment in patients with RCC. Journal for ImmunoTherapy of Cancer. 9(3). e001506–e001506. 28 indexed citations
4.
Siemers, Nathan O., James L. Holloway, Chang Han, et al.. (2017). Genome-wide association analysis identifies genetic correlates of immune infiltrates in solid tumors. PLoS ONE. 12(7). e0179726–e0179726. 162 indexed citations
5.
Kirov, Stefan, Heshani Desilva, Jian Cao, et al.. (2015). Sensitivity of Small Cell Lung Cancer to BET Inhibition Is Mediated by Regulation of ASCL1 Gene Expression. Molecular Cancer Therapeutics. 14(10). 2167–2174. 72 indexed citations
6.
7.
Choueiri, Toni K., Mayer Fishman, Bernard Escudier, et al.. (2015). Immunomodulatory activity of nivolumab in metastatic renal cell carcinoma (mRCC): Association of biomarkers with clinical outcomes.. Journal of Clinical Oncology. 33(15_suppl). 4500–4500. 21 indexed citations
8.
Chang, Han, Donald Jackson, Paul S. Kayne, et al.. (2011). Exome Sequencing Reveals Comprehensive Genomic Alterations across Eight Cancer Cell Lines. PLoS ONE. 6(6). e21097–e21097. 19 indexed citations
9.
Ji, Rui‐Ru, Heshani de Silva, Robert E. Bruccoleri, et al.. (2009). Transcriptional Profiling of the Dose Response: A More Powerful Approach for Characterizing Drug Activities. PLoS Computational Biology. 5(9). e1000512–e1000512. 22 indexed citations
10.
Ross‐Macdonald, Petra, Heshani de Silva, Qi Guo, et al.. (2008). Identification of a nonkinase target mediating cytotoxicity of novel kinase inhibitors. Molecular Cancer Therapeutics. 7(11). 3490–3498. 102 indexed citations
11.
Ross‐Macdonald, Petra. (2005). Forward in Reverse: How Reverse Genetics Complements Chemical Genetics. Pharmacogenomics. 6(4). 429–434. 3 indexed citations
12.
Carroll, Pamela M., et al.. (2003). Model systems in drug discovery: chemical genetics meets genomics. Pharmacology & Therapeutics. 99(2). 183–220. 38 indexed citations
13.
Zhan, Xiaoyan, Gerardo Abenes, Chonticha Kittinunvorakoon, et al.. (2000). Mutagenesis of Murine Cytomegalovirus Using a Tn3-Based Transposon. Virology. 266(2). 264–274. 35 indexed citations
14.
Ross‐Macdonald, Petra. (2000). Functional analysis of the yeast genome. Functional & Integrative Genomics. 1(2). 99–113. 8 indexed citations
15.
Ross‐Macdonald, Petra, Amy E. Sheehan, Carl Friddle, G. Shirleen Roeder, & M Snyder. (1999). [29] Transposon mutagenesis for the analysis of protein production, function, and localization. Methods in enzymology on CD-ROM/Methods in enzymology. 303. 512–532. 30 indexed citations
16.
17.
Neuvéglise, Cécile, Jean‐Marc Nicaud, Petra Ross‐Macdonald, & C. Gaillardin. (1998). A shuttle mutagenesis system for tagging genes in the yeast Yarrowia lipolytica. Gene. 213(1-2). 37–46. 18 indexed citations
18.
Ross‐Macdonald, Petra & G. Shirleen Roeder. (1994). Mutation of a meiosis-specific MutS homolog decreases crossing over but not mismatch correction. Cell. 79(6). 1069–1080. 311 indexed citations
19.
Ross‐Macdonald, Petra, Ralph Graeser, Barbara Kappes, Richard A. Franklin, & Donald H. Williamson. (1994). Isolation and expression of a gene specifying a cdc2‐like protein kinase from the human malaria parasite Plasmodium falciparum. European Journal of Biochemistry. 220(3). 693–701. 84 indexed citations
20.
Casimir, Colin, et al.. (1988). Structure and expression of a newt cardio-skeletal myosin gene. Journal of Molecular Biology. 202(2). 287–296. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nathan J. Bowen Breakdown of academic impact, for papers by Anthony J. Davis Breakdown of academic impact, for papers by Philip M. Sass Breakdown of academic impact, for papers by Tokameh Mahmoudi Breakdown of academic impact, for papers by Pascale Bertrand Breakdown of academic impact, for papers by Lawrence Weissbach Breakdown of academic impact, for papers by James W. Peacock Breakdown of academic impact, for papers by Philippe Coulombe Breakdown of academic impact, for papers by Anita Saraf Breakdown of academic impact, for papers by Helen Yu
Rankless by CCL
2026